Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study.
Yiwang XuAhmad MiremadiAlexander LinkPeter MalfertheinerRebecca C FitzgeraldJan BornscheinPublished in: Journal of clinical pathology (2019)
Assessment of serum PG1 could be combined with a test for Barrett's oesophagus to identify additional patients requiring endoscopy.